Liquidia

NASDAQ LQDA
$11.96 -0.18 -1.51%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 27 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

782.39M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

699.85M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

0.04
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

65.42M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-0.58 %

Upcoming events Liquidia

All events
No upcoming events scheduled

Stock chart Liquidia

Stock analysis Liquidia

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-9.79 8.79
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
16.54 25.38
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-9.84 4.40
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
1.16 0.50
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-168.93 9.54

Price change Liquidia per year

2.25$ 5.95$
Min Max

Summary analysis Liquidia

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Liquidia

Revenue and net income Liquidia

All parameters

Stock news Liquidia

All news

Liquidia Shares Down in Premarket as FDA Continues Review of Yutrepia Application

Liquidia Shares Down in Premarket as FDA Continues Review of Yutrepia Application

Liquidia Names CFO Kaseta As Operating Chief

Liquidia Names CFO Kaseta As Operating Chief

Liquidia Says FDA to Review Amended New Drug Application for Lung Cancer Treatment

Liquidia Says FDA to Review Amended New Drug Application for Lung Cancer Treatment

Liquidia Unable to Reverse Loss in United Therapeutics Patent Dispute

Liquidia Unable to Reverse Loss in United Therapeutics Patent Dispute

Liquidia in Revenue Interest Financing Agreement With HealthCare Royalty

Liquidia in Revenue Interest Financing Agreement With HealthCare Royalty

Liquidia stock price target cut to $4 from $6 at Wedbush

Liquidia Shares Fall 12% After Public Offering Pricing

Liquidia Shares Fall 12% After Public Offering Pricing

Liquidia Shares Up 8% After Needham Raises Price Target for Stock

Liquidia Shares Up 8% After Needham Raises Price Target for Stock

Liquidia Shares Hit 52-Week High After Co. Names Roger Jeffs CEO

Liquidia Shares Hit 52-Week High After Co. Names Roger Jeffs CEO

Liquidia Shares Rise 14% After Roger Jeffs Named CEO

Liquidia Shares Rise 14% After Roger Jeffs Named CEO

About company Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include LIQ861, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension; and LIQ865, a sustained-release formulation of bupivacaine for the treatment of local post-operative pain. The company also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Address:
419 Davis Drive, Morrisville, NC, United States, 27560
Company name: Liquidia
Issuer ticker: LQDA
ISIN: US53635D2027
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2018-07-26
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.liquidia.com

On which stock exchange are Liquidia (LQDA) stocks traded?

Liquidia (LQDA) stocks are traded on NASDAQ.

What is the ticker of Liquidia stocks (LQDA)?

The stock ticker of Liquidia’s stocks or in other words, the code is LQDA. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Liquidia (LQDA) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Liquidia (LQDA) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Liquidia (LQDA) stocks traded?

Liquidia (LQDA) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Liquidia (LQDA) stocks today?

The current price of Liquidia stocks on 15.05.2024 is 11.96 dollars. per share.

What is the dynamics of Liquidia (LQDA) stocks from the beginning of the year?

Liquidia (LQDA) quotes have increased by 3.73% from the beginning of the year up to 11.96 dollars. per 1 stocks.

How much did Liquidia (LQDA) stocks increase in мае 2024?

This month Liquidia (LQDA) quotes have increased by -9.19% to 11.96 dollars. per share.

How much are Liquidia (LQDA) stocks worth?

Today, on October, 15.05.2024 Liquidia’s (LQDA) stocks cost 11.96 dollars..

What is the market capitalization of Liquidia (LQDA)?

Capitalization is the market value of Liquidia (LQDA) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 15.05.2024, the market capitalization of Liquidia (LQDA) is estimated at about 782390011 dollars.